Mustang Bio effects 1-for-50 reverse stock split to regain Nasdaq compliance

MUSTANG BIO, INC.

Outstanding shares reduced from ~64.8M to ~1.3M; split effective Jan 15, 2025.
Trading on split-adjusted basis under symbol MBIO begins Jan 16, 2025.
Reverse split intended to meet Nasdaq's $1.00 minimum bid price requirement.
No fractional shares issued; cash payment in lieu for fractional entitlements.
New CUSIP 62818Q302; board set final ratio on Jan 6, 2025 per prior stockholder approval.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

MUSTANG BIO, INC.: Amendment to Certificate of Incorporation to effect a 1-for-50 reverse stock split (effective 2025-01-15).

Change: charter amendment
Effective: 2025-01-15

Exact text from the filing

On January 15, 2025, Mustang Bio, Inc. (the “Company”) filed a Certificate of Amendment (the “Amendment”) to its Amended and Restated Certificate of Incorporation, as amended, with the Secretary of State of the State of Delaware to effect a 1-for-50 reverse stock split (the “Reverse Stock Split”) of the Company’s shares of common stock, $0.0001 par value.

View on SEC.gov

Browse all governance changes →

MUSTANG BIO, INC. filing history →

Source: SEC EDGAR

accession 0001104659-25-004565

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.